These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 7031905)

  • 1. [Mechanism of the action of allopurinol].
    Pikhlak EG; Piliaev VG
    Sov Med; 1981; (10):111-4. PubMed ID: 7031905
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the dose-effect relation of allopurinol (author's transl)].
    Mertz DP
    Arzneimittelforschung; 1977; 27(6):1209-11. PubMed ID: 578444
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Uric-acid reduction with high allopurinol dosages (author's transl)].
    Mertz DP; Loewer H
    Dtsch Med Wochenschr; 1979 Mar; 104(9):324-5. PubMed ID: 761542
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effectiveness and tolerance of long-term uricosuric treatment].
    Berg H
    Z Gesamte Inn Med; 1990 Dec; 45(23):719-20. PubMed ID: 2102029
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intermittent control of hyperuricemia in the treatment of gout.
    Bull PW; Scott JT
    J Rheumatol; 1989 Sep; 16(9):1246-8. PubMed ID: 2681764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The efficacy of combined low dose of Allopurinol and benzbromarone compared to standard dose of Allopurinol in hyperuricemia.
    Akkasilpa S; Osiri M; Deesomchok U; Avihingsanon Y
    J Med Assoc Thai; 2004 Sep; 87(9):1087-91. PubMed ID: 15516011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of asymptomatic hyperuricemia].
    Floege J
    Internist (Berl); 1997 Dec; 38(12):1233. PubMed ID: 9465329
    [No Abstract]   [Full Text] [Related]  

  • 8. Efficacy of benzbromarone compared to allopurinol in lowering serum uric acid level in hyperuricemic patients.
    Hanvivadhanakul P; Akkasilpa S; Deesomchok U
    J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S40-7. PubMed ID: 12188443
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of febuxostat versus allopurinol and placebo in reducing serum urate in subjects with hyperuricemia and gout: a 28-week, phase III, randomized, double-blind, parallel-group trial.
    Schumacher HR; Becker MA; Wortmann RL; Macdonald PA; Hunt B; Streit J; Lademacher C; Joseph-Ridge N
    Arthritis Rheum; 2008 Nov; 59(11):1540-8. PubMed ID: 18975369
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose adjustment of allopurinol according to creatinine clearance does not provide adequate control of hyperuricemia in patients with gout.
    Dalbeth N; Kumar S; Stamp L; Gow P
    J Rheumatol; 2006 Aug; 33(8):1646-50. PubMed ID: 16783857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The influence of allopurinol on the course of gout. A study of 28 cases.
    Kawenoki-Minc E; Eyman E; Sopata I; Weryńska-Przybylska J
    Reumatologia; 1970; 8(3):177-92. PubMed ID: 5469423
    [No Abstract]   [Full Text] [Related]  

  • 12. Single daily dose of allopurinol.
    Brewis I; Ellis RM; Scott JT
    Ann Rheum Dis; 1975 Jun; 34(3):256-9. PubMed ID: 1098582
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Allopurinol in the treatment of gout].
    Klein G; Griendl W; Kalb R
    Z Rheumaforsch; 1968 Dec; 27(11):455-60. PubMed ID: 5710881
    [No Abstract]   [Full Text] [Related]  

  • 14. Higher therapeutic plasma oxypurinol concentrations might be required for gouty patients with chronic kidney disease.
    Panomvana D; Sripradit S; Angthararak S
    J Clin Rheumatol; 2008 Feb; 14(1):6-11. PubMed ID: 18431090
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Therapeutic efficacy of slow-release allopurinol in gout and hyperuricaemia (author's transl)].
    Dunky A; Nitsche V; Eberl R
    Wien Klin Wochenschr; 1981 Jan; 93(2):65-8. PubMed ID: 7245774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Allopurinol in the treatment of gout. Preliminary report].
    Lignière GC; Cirla E
    Reumatismo; 1968; 20(2):101-3. PubMed ID: 5748155
    [No Abstract]   [Full Text] [Related]  

  • 17. [The use of allopurinol in long-term treatments for optimal effect].
    Fenner H
    Fortschr Med; 1980 Mar; 98(10):(373-6). PubMed ID: 7372221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [How to treat hyperuricemia and gout attacks in compensated kidney failure?].
    Gröbner W
    Dtsch Med Wochenschr; 2002 Mar; 127(11):576. PubMed ID: 11894180
    [No Abstract]   [Full Text] [Related]  

  • 19. [Early diagnosis and early treatment of gout].
    Mertz DP
    Hippokrates; 1968 Jan; 39(1):5-12. PubMed ID: 5667616
    [No Abstract]   [Full Text] [Related]  

  • 20. [Simplification of allopurinol treatment].
    Zöllner N; Griebsch A
    MMW Munch Med Wochenschr; 1974 Sep; 116(39):1691-2. PubMed ID: 4216779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.